Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 8
2008 5
2009 2
2010 12
2011 5
2012 2
2013 4
2014 1
2015 5
2016 1
2017 2
2018 2
2019 2
2020 2
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab-related viral infections in lymphoma patients.
Aksoy S, Harputluoglu H, Kilickap S, Dede DS, Dizdar O, Altundag K, Barista I. Aksoy S, et al. Among authors: dede ds. Leuk Lymphoma. 2007 Jul;48(7):1307-12. doi: 10.1080/10428190701411441. Leuk Lymphoma. 2007. PMID: 17613758 Review.
Do all aromatase inhibitors have similar efficacy and safety?
Şendur MA, Bilgin B, Hızal M, Özdemir NY, Akıncı MB, Dede DŞ, Yalçın B. Şendur MA, et al. Among authors: dede ds. Future Oncol. 2017 Aug;13(19):1673-1676. doi: 10.2217/fon-2017-0228. Epub 2017 Aug 23. Future Oncol. 2017. PMID: 28831832 Free article. No abstract available.
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study.
Bilgin B, Sendur MAN, Yucel S, Celik E, Ozyukseler DT, Ayhan M, Basoglu T, Ilhan A, Akdeniz N, Gulmez A, Dogan I, Aktas BY, Gurbuz M, Koca S, Paydas S, Tatli AM, Cinkir HY, Alan O, Erol C, Hizal M, Kut E, Menevse S, Sakalar T, Taskaynatan H, Deniz GI, Karaagac M, Avci O, Sen E, Karatas F, Akinci MB, Dede DS, Demir A, Demirkazık A, Oksuzoglu B, Kilickap S, Yumuk F, Yalcin B. Bilgin B, et al. Among authors: dede ds. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6. Epub 2021 Jan 12. J Cancer Res Clin Oncol. 2021. PMID: 33433657
Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data.
Özdemir N, Dizdar Ö, Yazıcı O, Aksoy S, Dede DS, Budakoğlu B, Metan G, Alp A, Budakoğlu II, Öksüzoğlu ÖBÇ, Özet A, Kılıçkap S, Turhal NS, Çelik İ, Erman M, Ata N, Çelik O, Hayran M. Özdemir N, et al. Among authors: dede ds. Int J Cancer. 2020 Dec 7. doi: 10.1002/ijc.33426. Online ahead of print. Int J Cancer. 2020. PMID: 33284987 Free article.
Blood ABO groups and risk of breast cancer.
Dede DS, Aksoy S, Dizdar O, Cerci P, Gullu I, Ozisik Y, Altundag K. Dede DS, et al. Med Oncol. 2010 Dec;27(4):1433. doi: 10.1007/s12032-009-9346-1. Med Oncol. 2010. PMID: 19885747 No abstract available.
53 results